Login

Ownership

13F as of Q2 2026 · 41.8M shares outstanding

Who owns Carisma Therapeutics Inc.?

By type of holder
Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Concentration Top 1 holders own 0.0%
Union Bancaire Privee, UBP SA 0.0%
Institutional ownership
0.0%
-3.5 pts vs last qtr
Institutional holders
1
-2 vs last qtr
Net shares bought
−1.5M
by institutions in Q2 2026
New / sold out
0 / 2
positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026
  • Merck & Co., Inc. SOLD OUT −1.5M
  • Ascentis Independent Advisors SOLD OUT −200

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Carisma Therapeutics Inc. in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2015–FY2024
+118.3%
+9.06% a year
Each share's claim on the business
−54.2%
shrank without buying or selling a share
Spent on buybacks vs paid in stock
— vs $23.6M
over 10 fiscal years
Diluted shares, split-adjusted
2.1M93.1M184.1M2015: 19.0M shares'152016: 21.7M shares'162017: 26.1M shares'172018: 61.8M shares'182019: 90.9M shares'192020: 118.2M shares'202021: 182.3M shares'212022: 2.1M shares'222023: 33.5M shares'232024: 41.5M shares'24
Buybacks Stock-based comp
$0$2.6M$5.1M2015 buybacks: $02015 stock comp: $2.5M'152016 buybacks: $02016 stock comp: $4.0M'162017 buybacks: $02017 stock comp: $1.4M'172018 buybacks: $02018 stock comp: $1.3M'182019 buybacks: $02019 stock comp: $1.2M'192020 buybacks: $02020 stock comp: $1.8M'202021 buybacks: $02021 stock comp: $5.1M'212022 buybacks: $02022 stock comp: $275.0K'222023 buybacks: $02023 stock comp: $2.3M'232024 buybacks: $02024 stock comp: $3.6M'24

How patient are the owners?

Institutional shares by how long they've been held
5+ years0% 3–5 years0% 1–3 years100% Under 1 year0%
Quarterly turnover
50.0%
of institutional shares changed hands
Top 10 managers, median time held
1.5 years

Super Investors

Investment managers reporting Carisma Therapeutics Inc. on Form 13F
M
Merck & Co., Inc.
Shares
—
% of company
—
Change vs last qtr
SOLD OUT
Held since
—
UB
Union Bancaire Privee, UBP SA
Shares
785
% of company
0.00%
Change vs last qtr
Unchanged
Held since
2024

1 more super investors behind a free account

See every manager holding Carisma Therapeutics Inc., how their position has changed, and how long they've held it.

Sign up free

Institutional Funds

Mutual funds and ETFs reporting Carisma Therapeutics Inc. on Form N-PORT; together they hold 0.0% of the company
GA
Guggenheim Active Allocation Fund
Guggenheim Active Allocation Fund
Position value
$0.08
% of company
0.00%
% of the fund
0.00%
As of
August 31, 2026

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support